Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Negative effect of HLA-DR matching on corneal transplant rejection.

× No keyword cloud information.

8 in total

Review 1. Experimental corneal allograft rejection.

Authors: Bryan M Gebhardt; Weiyun Shi
Journal: Immunol Res Date: 2002 Impact factor: 2.829

Review 2. [Tissue typing in perforating corneal transplantation].

Authors: J Wachtlin; R Khaireddin; F Hoffmann
Journal: Ophthalmologe Date: 2003-12 Impact factor: 1.059

3. Conclusions of the corneal transplant follow up study. Collaborating Surgeons.

Authors: A Vail; S M Gore; B A Bradley; D L Easty; C A Rogers; W J Armitage
Journal: Br J Ophthalmol Date: 1997-08 Impact factor: 4.638

4. Update on the Management of High-Risk Penetrating Keratoplasty.

Authors: Sayena Jabbehdari; Alireza Baradaran Rafii; Ghasem Yazdanpanah; Pedram Hamrah; Edward J Holland; Ali R Djalilian
Journal: Curr Ophthalmol Rep Date: 2017-02-02

5. Influence of HLA-A, HLA-B, and HLA-DR matching on rejection of random corneal grafts using corneal tissue for retrospective DNA HLA typing.

Authors: M C Bartels; H G Otten; B E van Gelderen; A Van der Lelij
Journal: Br J Ophthalmol Date: 2001-11 Impact factor: 4.638

Negative effect of HLA-DR matching on corneal transplant rejection.

Review 1. Experimental corneal allograft rejection.

Review 2. [Tissue typing in perforating corneal transplantation].

3. Conclusions of the corneal transplant follow up study. Collaborating Surgeons.

4. Update on the Management of High-Risk Penetrating Keratoplasty.

5. Influence of HLA-A, HLA-B, and HLA-DR matching on rejection of random corneal grafts using corneal tissue for retrospective DNA HLA typing.

6. HLA-A, HLA-B and HLA-DR matching reduces the rate of corneal allograft rejection.

7. Operational post-keratopasty graft tolerance due to differential HLAMatchmaker matching.

8. Corneal Allograft Rejection: Immunopathogenesis to Therapeutics.